These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Rajfer J, Aliotta PJ, Steidle CP, Fitch WP, Zhao Y, Yu A. Int J Impot Res; 2007; 19(1):95-103. PubMed ID: 16871272 [Abstract] [Full Text] [Related]
23. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction. Broderick GA, Brock GB, Roehrborn CG, Watts SD, Elion-Mboussa A, Viktrup L. Urology; 2010 Jun; 75(6):1452-8. PubMed ID: 20163842 [Abstract] [Full Text] [Related]
24. Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction. Saylan M, Khalaf I, Kadioglu A, Shoair KZ, Beheiry A, Wang WC, Kopernicky V, Esen A. Int J Clin Pract; 2006 Jul; 60(7):812-9. PubMed ID: 16846400 [Abstract] [Full Text] [Related]
25. Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials. Shabsigh R, Burnett AL, Eardley I, Sharlip ID, Ellsworth PI, Garcia CS, Natanegara F, Ahuja S. BJU Int; 2005 Oct; 96(6):857-63. PubMed ID: 16153217 [Abstract] [Full Text] [Related]
26. The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study. Wespes E, Moncada I, Schmitt H, Jungwirth A, Chan M, Varanese L. BJU Int; 2007 Jan; 99(1):121-6. PubMed ID: 17227498 [Abstract] [Full Text] [Related]
27. [Efficacy and safety of long-term small-dose tadalafil in the treatment of erectile dysfunction]. Xu WD, Liu ZY, Ye HM, Lu X, Xu CL, Ji JT, Piao SG, Sheng X. Zhonghua Nan Ke Xue; 2011 Jun; 17(6):531-4. PubMed ID: 21735653 [Abstract] [Full Text] [Related]
28. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials. Rosen RC, Shabsigh R, Kuritzky L, Wang WC, Sides GD. Curr Med Res Opin; 2005 Nov; 21(11):1701-9. PubMed ID: 16307689 [Abstract] [Full Text] [Related]
29. [Observation of safety and efficacy of tadalafil for men with erectile dysfunction]. Zhu XW, Li FY, Fang JJ. Zhonghua Nan Ke Xue; 2006 May; 12(5):421-3, 427. PubMed ID: 16755872 [Abstract] [Full Text] [Related]
30. The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients. Hazell L, Cornelius V, Wilton LV, Shakir SA. BJU Int; 2009 Feb; 103(4):506-14. PubMed ID: 18990133 [Abstract] [Full Text] [Related]
31. The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners. Brock G, Chan J, Carrier S, Chan M, Salgado L, Klein AH, Lang C, Horner R, Gutkin S, Dickson R. BJU Int; 2007 Feb; 99(2):376-82. PubMed ID: 17155989 [Abstract] [Full Text] [Related]
32. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L. J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631 [Abstract] [Full Text] [Related]
34. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study. Hatzichristou D, Haro JM, Martin-Morales A, von Keitz A, Riley A, Bertsch J, Belger M, Wolka AM, Beardsworth A, EDOS Group. Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306 [Abstract] [Full Text] [Related]
36. Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US. Goldstein I, Kim E, Steers WD, Pryor JL, Wilde DW, Natanegara F, Wong DG, Ahuja S. J Sex Med; 2007 Jan; 4(1):166-175. PubMed ID: 17233782 [Abstract] [Full Text] [Related]
37. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian 'Treatment of Erectile Dysfunction' observational study. Lee J, Pommerville P, Brock G, Gagnon R, Mehta P, Krisdaphongs M, Chan M, Chan J, Dickson R. BJU Int; 2006 Sep; 98(3):623-9. PubMed ID: 16925764 [Abstract] [Full Text] [Related]
38. Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study. Chen KK, Jiann BP, Lin JS, Lee SS, Huang ST, Wang CJ, Ju-Ton H, Su CK, Costigan TM, Emmick JT. J Sex Med; 2004 Sep; 1(2):201-8. PubMed ID: 16422975 [Abstract] [Full Text] [Related]
39. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy. Eardley I, Mirone V, Montorsi F, Ralph D, Kell P, Warner MR, Zhao Y, Beardsworth A. BJU Int; 2005 Dec; 96(9):1323-32. PubMed ID: 16287454 [Abstract] [Full Text] [Related]
40. Integrated analysis examining first-dose success, success by dose, and maintenance of success among men taking tadalafil for erectile dysfunction. Schulman CC, Shen W, Stothard DR, Schmitt H. Urology; 2004 Oct; 64(4):783-8. PubMed ID: 15491720 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]